Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Microbial Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1514296
This article is part of the Research Topic The Host and Pathogen Determinants of Tuberculosis Spectrum Diseases View all articles

The autoimmune disease risk variant NCF1-His90 is associated with a reduced risk of tuberculosis in women

Provisionally accepted
Xinjun Hu Xinjun Hu 1,2Shasha Li Shasha Li 3Huang Renliang Huang Renliang 4Zheng Cheng Zheng Cheng 3Chenyu Ma Chenyu Ma 1,2Ziwei Fu Ziwei Fu 3Hongjun Hu Hongjun Hu 5Qiaomiao Zhou Qiaomiao Zhou 4Frank Petersen Frank Petersen 6Xinhua Yu Xinhua Yu 4,6*JF Zheng JF Zheng 3,7*
  • 1 Department of Infectious Diseases, The First Affiliated Hospital of Henan University of Science and Technology,, Luoyang, China
  • 2 Henan Medical Key Laboratory of Gastrointestinal Microecology and Hepatology, Luoyang, China
  • 3 Institute of Psychiatry and Neuroscience, Xinxiang Medical University, Xinxiang, Henan Province, China
  • 4 Hainan Women and Children's Medical Center, Haikou, Hainan Province, China
  • 5 Department of Surgical Oncology, Xinxiang Central Hospital, The Fourth Clinical of Xinxiang Medical University,, Xinxiang, China
  • 6 Priority Area Chronic Lung Diseases, Research Center Borstel, Borstel, Germany
  • 7 Xinxiang Medical University, Xinxiang, China

The final, formatted version of the article will be published soon.

    Introduction. The neutrophil cytosolic factor 1 (NCF1) rs201802880 polymorphism is a missense mutation resulting in an amino acid substitution from arginine to histidine at position 90, which impairs the function of NADPH oxidase. This casual variant confers an increased risk for multiple autoimmune disorders, including primary Sjögren’s syndrome and systemic lupus erythematosus. Given the high prevalence of this autoimmune disease risk variant in East Asia, we hypothesized that it may confer an evolutionary advantage by providing protection against infectious diseases. Methods. To test this hypothesis, we investigated whether the NCF1 rs201802880 variant offers a protective effect against tuberculosis (TB), a historically significant and deadly infectious disease. Our study included 490 healthy controls and 492 TB patients who were genotyped for the NCF1 rs201802880 polymorphism. Results. Our results showed that the NCF1 rs201802880 AA genotype was associated with a reduced risk of TB in women (OR= 0.25, 95% CI: 0.09-0.68, p=0.0023). Additionally, healthy individuals with the NCF1 rs201802880 AA genotype had significantly lower circulating white blood cell (5.56 ± 1.78 vs 6.43 ± 1.59, p=0.003) and neutrophil (3.23 ± 1.20 vs 3.74 ± 1.23, p = 0.02) counts compared to those with the GG or GA genotypes, with this difference being more pronounced in women than in men. Conclusion. This study demonstrates that the autoimmune disease-causal NCF1 variant is associated with a protective effect against TB infection.

    Keywords: Autoimmune diseases (AD), Infectious diseases, neutrophil cytosolic factor 1 (Ncf1), Genetic association, Evolutionary trade-offs, Tuberculosis

    Received: 20 Oct 2024; Accepted: 08 Jan 2025.

    Copyright: © 2025 Hu, Li, Renliang, Cheng, Ma, Fu, Hu, Zhou, Petersen, Yu and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Xinhua Yu, Hainan Women and Children's Medical Center, Haikou, Hainan Province, China
    JF Zheng, Xinxiang Medical University, Xinxiang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.